37 results
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
patients with Opportunistic ... Infections • Pulmonary ... count <50 • Pulmonary ... of starting OI treatment ... Therapy #HAART #HIV #Opportunistic
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Medications #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Aspergillosis Treatment ... • Invasive pulmonary ... Aspergillosis #Treatment ... #management #pharmacology
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
management in Pulmonary ... #prescribing #Pulmonary ... Management #Algorithm #treatment ... #pharmacology
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Medical Treatment ... Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... Algorithm #Management #Pulmonary ... SABA #SAMA #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... #Management #Pulmonary
Choice of anticoagulant for treatment of pulmonary embolism
 • Malignancy - LMWH
 • To avoid parenteral
anticoagulant for treatment ... of pulmonary embolism ... anticoagulation #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
previously diagnosed opportunistic ... of preexisting opportunistic ... Lymphadenitis, pulmonary ... lymphadenitis, pulmonary ... , hypoxia, and pulmonary
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Disease Note: Treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for effective treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology